Samrudh Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 21 regulatory filings across 5 regulators, without an active US DMF or CEP on file. Its filings concentrate with NAFDAC (NG), DAV (Vietnam) and UZPHARM (UZ). Its GMP standing is certified by UZPHARM (UZ) and NAFDAC (NG). Customs aggregates show $298K of exports covering 34 molecules to 2 destinations in 2026 so far.
| Site | FDA FEI |
|---|---|
| Palghar Maharashtra, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| NAFDAC (NG) | 7 | 1 |
| DAV (Vietnam) | 7 | None |
| UZPHARM (UZ) | 5 | 2 |
| ARCSA (EC) | 1 | None |
| MINSA (CR) | 1 | None |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $298K | 2 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Samrudh Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.